Persistence of Immune Responses to Altered and Native Myelin Antigens in Patients with Multiple Sclerosis Treated with Altered Peptide Ligand

By Kim H.J.   Antel J.P.   Duquette P.   Alleva D.G.   Conlon P.J.   Bar-Or A.  

Clinical Immunology, Vol. 104, Iss. 2, 2002-08 ,pp. : 105-114

Academic Press

Access to resources Recommend Favorite

Altered plasma albumin characteristics and lymphocyte populations in gastrointestinal cancer patients: Detection using modified fluorescence responses

By Kalnina Inta   Kirilova Elena   Klimkane Laura   Kirilov Georgii  

Journal of Immunotoxicology, Vol. 6, Iss. 4, 2009-12 ,pp. : 293-300

Informa Healthcare

Access to resources Recommend Favorite

Dissection of B cell differentiation during primary immune responses in mice with altered CD40 signals

By Kikutani H.  

International Immunology, Vol. 14, Iss. 3, 2002-03 ,pp. : 319-329

Oxford University Press

Access to resources Recommend Favorite

Altered Signaling Lymphocytic Activation Molecule (SLAM) Expression in HIV Infection and Redirection of HIV-Specific Responses via SLAM Triggering

By Meroni L.   Fusi M.L.   Varchetta S.   Biasin M.   Rusconi S.   Villa M.L.   de Vries J.E.   Aversa G.   Galli M.   Clerici M.  

Clinical Immunology, Vol. 92, Iss. 3, 1999-09 ,pp. : 276-284

Academic Press

Access to resources Recommend Favorite

Changes in the strength of co-stimulation through the B7/CD28 pathway alter functional T cell responses to altered peptide ligands

By Kuchroo V.  

International Immunology, Vol. 11, Iss. 3, 1999-03 ,pp. : 407-416

Oxford University Press

Access to resources Recommend Favorite